JOSEPHINE SMITH: Open Payments
NPI 1073897880 · BAYONNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,027 in 65 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $366 · 2025 $1,027
Food & beverage: $1,027
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $187 |
| Neurocrine BioSciences, Inc. | 12 | $168 |
| Teva Pharmaceuticals USA, Inc. | 9 | $145 |
| E.R. Squibb & Sons, L.L.C. | 12 | $144 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $116 |
| Supernus Pharmaceuticals, Inc. | 5 | $81 |
| Lundbeck LLC | 4 | $71 |
| Vanda Pharmaceuticals Inc. | 3 | $49 |
| Alkermes, Inc. | 1 | $23 |
| Almatica Pharma LLC | 1 | $17 |
Products named: REXULTI, INGREZZA, AUSTEDO XR, COBENFY, CAPLYTA, Qelbree, FANAPT, ARISTADA.
Industry payments across NJ — which companies pay providers there.
